The TGF-β pathway, produced by tumor cells, CAFs, and mesenchymal stem cells, drives immune suppression by promoting the expansion of Tregs and M2 macrophages, both of which inhibit anti-tumor immunity. The gene discussed is TGFB1; the disease is neoplasm.